These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 27554324)

  • 1. Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/β-catenin signalling pathway.
    Du L; Nong MN; Zhao JM; Peng XM; Zong SH; Zeng GF
    Sci Rep; 2016 Aug; 6():32261. PubMed ID: 27554324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygonatum Sibiricum Polysaccharide Promotes Osteoblastic Differentiation Through the ERK/GSK-3β/β-Catenin Signaling Pathway In Vitro.
    Peng X; He J; Zhao J; Wu Y; Shi X; Du L; Nong M; Zong S; Zeng G
    Rejuvenation Res; 2018 Feb; 21(1):44-52. PubMed ID: 28629266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role and Mechanism of miRNA-1224 in the
    Li B; Wu P; Fu W; Xiong Y; Zhang L; Gao Y; Deng G; Zong S; Zeng G
    Rejuvenation Res; 2019 Oct; 22(5):420-430. PubMed ID: 30632458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
    Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
    J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
    Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Polygonatum sibiricum polysaccharide on the osteogenic differentiation of bone mesenchymal stem cells in mice.
    Zong S; Zeng G; Zou B; Li K; Fang Y; Lu L; Xiao D; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(6):6169-80. PubMed ID: 26261494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib prevents ovariectomy-induced osteoporosis in mice by inhibiting osteoclast differentiation.
    Kim SH; Kim MO; Kim HJ; Neupane S; Kim HJ; Lee JH; Kim HH; Kim JY; Lee Y
    J Bone Miner Metab; 2018 Sep; 36(5):537-546. PubMed ID: 29027021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
    Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
    Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid β peptide promotes bone formation by regulating Wnt/β-catenin signaling and the OPG/RANKL/RANK system.
    Yang B; Li S; Chen Z; Feng F; He L; Liu B; He T; Wang X; Chen R; Chen Z; Xie P; Rong L
    FASEB J; 2020 Mar; 34(3):3583-3593. PubMed ID: 31944393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.
    Ye C; Hou W; Chen M; Lu J; Chen E; Tang L; Hang K; Ding Q; Li Y; Zhang W; He R
    Cell Prolif; 2020 Feb; 53(2):e12752. PubMed ID: 31889368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo.
    Kuang Z; Yang X; Cao Z; Li Y; Hu J; Hong X; Li B; Wu C; Qi Q; Liu X; Dai M
    Int Immunopharmacol; 2023 Apr; 117():109884. PubMed ID: 36805201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway.
    Liu YQ; Hong ZL; Zhan LB; Chu HY; Zhang XZ; Li GH
    Sci Rep; 2016 Aug; 6():32260. PubMed ID: 27558652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
    Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
    Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carfilzomib alleviated osteoporosis by targeting PSME1/2 to activate Wnt/β-catenin signaling.
    Zhang F; Attarilar S; Xie K; Han C; Qingyang Liang ; Huang K; Lan C; Wang C; Yang C; Wang L; Mozafari M; Li K; Liu J; Tang Y
    Mol Cell Endocrinol; 2022 Jan; 540():111520. PubMed ID: 34838695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.
    Xu S; Zhang Y; Liu B; Li K; Huang B; Yan B; Zhang Z; Liang K; Jia C; Lin J; Zeng C; Cai D; Jin D; Jiang Y; Bai X
    J Bone Miner Res; 2016 Jul; 31(7):1320-33. PubMed ID: 26825871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
    Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
    Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extract of Magnoliae Flos inhibits ovariectomy-induced osteoporosis by blocking osteoclastogenesis and reducing osteoclast-mediated bone resorption.
    Jun AY; Kim HJ; Park KK; Son KH; Lee DH; Woo MH; Kim YS; Lee SK; Chung WY
    Fitoterapia; 2012 Dec; 83(8):1523-31. PubMed ID: 22981503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.